Last Price$11.10.1%
Market Cap$1,440.8M
LTM Long-Term Investments
$0.0
YoY Growth
N/A
3Y CAGR
N/A
5Y CAGR
N/A
Stock quality & Intrinsic value
6/10
28.0% undervalued
Enfusion, Inc. Long-Term Investments
Annual
Quarterly
LTM
Crunching data... Almost there!
| Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | |
|---|---|---|---|---|---|---|
| Long-Term Investments | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 |
Overvalued or undervalued?
Check the intrinsic value for ENFN
and see if it's the right time to invest.
Enfusion, Inc. (ENFN) Long-Term Investments comparison analysis
General
LTM Long-Term Investments
Growth
Company name
YoY growth
3Y CAGR
5Y CAGR
Enfusion, Inc.ENFN
$0.0
N/A
N/A
N/A
Median Peer Set
$2,117.5M
(15.6%)
0.0%
9.9%
Uber Technologies, Inc.UBER
$8,762.0M
(32.6%)
(11.4%)
(5.9%)
SAP SESAP
$7,610.9M
25.3%
5.4%
25.8%
Shopify Inc.SHOP
$5,998.0M
37.0%
14.9%
374.3%
Salesforce, Inc.CRM
$4,852.0M
0.1%
0.5%
19.8%
ServiceNow, Inc.NOW
$4,111.0M
28.3%
36.1%
32.3%
Cadence Design Systems, Inc.CDNS
$124.1M
(50.3%)
(0.9%)
(2.1%)
Intuit Inc.INTU
$88.0M
(31.3%)
(0.7%)
46.6%
AppLovin CorporationAPP
$0.0
(100.0%)
N/A
N/A
MicroStrategy IncorporatedMSTR
$0.0
N/A
N/A
N/A
Workday, Inc.WDAY
$0.0
(100.0%)
(100.0%)
(100.0%)
ENFN key stats
USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
| Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | |
|---|---|---|---|---|---|---|
% growth | 59.0 0.0% | 79.6 34.8% | 111.7 40.4% | 150.3 34.6% | 174.5 16.1% | 201.6 15.5% |
| Cost of Goods Sold (COGS) | 17.0 | 21.4 | 31.8 | 47.1 | 57.6 | 64.9 |
% margin | 42.1 71.3% | 58.2 73.2% | 79.9 71.5% | 103.2 68.7% | 116.9 67.0% | 136.7 67.8% |
| Operating Expenses | 28.2 | 52.1 | 355.7 | 115.2 | 104.9 | 130.6 |
| Research & Development Expenses (R&D) | 4.1 | 6.3 | 153.4 | 17.2 | 19.9 | 26.7 |
| Selling, General & Administrative Expenses (SG&A) | 24.1 | 45.8 | 202.3 | 98.1 | 85.1 | 103.9 |
% margin | 13.9 23.5% | 6.1 7.6% | (275.9) (247.0%) | (12.0) (8.0%) | 11.9 6.8% | 6.2 3.1% |
| Interest Income | 0.7 | 1.7 | 4.6 | 0.4 | 0.0 | 1.7 |
| Interest Expense | 0.7 | 1.7 | 4.6 | 0.4 | 0.0 | 0.0 |
| Pre-tax Income | 13.1 | 4.5 | (281.7) | (12.2) | 11.5 | 7.4 |
% effective tax rate | 0.5 3.7% | 0.4 9.6% | 0.6 (0.2%) | 1.1 (8.8%) | 2.2 19.4% | 4.6 61.8% |
% margin | 12.7 21.4% | 4.1 5.1% | (282.2) (252.7%) | (13.3) (8.8%) | 6.0 3.5% | 2.8 1.4% |
| EPS | 0.11 | 0.04 | (4.30) | (0.16) | 0.10 | 0.02 |
| Diluted EPS | 0.11 | 0.04 | (4.30) | (0.16) | 0.07 | 0.01 |
% margin | 15.0 25.5% | 8.4 10.5% | (271.9) (243.4%) | (5.6) (3.7%) | 21.9 12.6% | 6.2 3.1% |
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 35.3%
S&P Outperformance 22.3%
Next 3M Predicted Return 26.8%
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.
3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%
FAQ
1) What is Enfusion, Inc.'s Long-Term Investments?
As of today, Enfusion, Inc.'s last 12-month Long-Term Investments is $0.0, based on the financial report for Dec 31, 2024 (Q4’2024).
2) What is Enfusion, Inc.'s Long-Term Investments growth rate?
Over the last year, Enfusion, Inc.'s Long-Term Investments growth was N/A. The average annual Long-Term Investments growth rates for Enfusion, Inc. have been N/A over the past three years, N/A over the past five years.